Chief Operating Officer · Tyra Biosciences, Inc. (TYRA)

Daniel Bensen

A named executive officer of Tyra Biosciences in every fiscal year CompBrief holds from FY2023 to FY2024. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2024

$2,655,199

Salary $475,900Stock awards $0

FY2023: $1,919,933

3rd of 3 named executive officers at Tyra Biosciences by FY2024 total.

3 named officers on file for Tyra Biosciences, FY2024

Daniel Bensen’s pay file — $29

  • 2 fiscal years of pay, line by line

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Tyra Biosciences’s whole pay program stands against its peers

  • Tyra Biosciences’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on TYRA→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 18, 2025 (DEF 14A). Insider transactions since that proxy, current to 2026-11-21.

Free

Get Daniel Bensen’s full pay file as a PDF — free

More than this page: up to 10 years of Daniel’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Daniel Bensen compensation by year

Tyra Biosciences Summary Compensation Table · all 2 fiscal years held
In US dollars, as Tyra Biosciences reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2023FY2024
Salary$457,600$475,900
Bonus$0$0
Stock awards$0$0
Option awards$1,186,823$1,917,556
Non-equity incentive$274,560$260,793
Pension and deferred compensation$0$0
All other$950$950
Total$1,919,933$2,655,199

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Tyra Biosciences, Inc. DEF 14A filed April 18, 2025, accession 0001193125-25-085709, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Tyra Biosciences, Inc. filed document, accession 0001193125-25-085709. Every figure is read from that document and cited to the page and table it appears in. Filed April 18, 2025.

$1.9M
$2.7M
FY23
FY24
SalaryNon-equity incentiveOption awardsAll other

Equity holdings

unvested awards at FY2024 year-end
TypeUnvested unitsValue at year-endExercise price
Option8,434—$2.25
Option19,165—$24.15
Option45,938—$7.14
Option62,383—$7.14
Option71,042—$14.35
Option105,417—$21.57

Per the Outstanding Equity Awards at Fiscal Year-End table in Tyra Biosciences, Inc.'s FY2024 proxy; value at the fiscal year-end close, as the company printed it.

Insider transactions since the last proxy

12 Form 4 lines since the FY2024 proxy (filed April 18, 2025)
current to 2026-11-21 · updated nightly
DateTransactionPlanSharesPriceHeld after
2026-02-12Sale10b5-12,128$31.50152,853
2026-02-12Sale10b5-15,872$33.37146,981
2026-01-12Sale10b5-16,983$28.44155,998
2026-01-12Sale10b5-11,017$29.08154,981
2025-12-12Sale10b5-18,000$22.64162,981
2025-11-19Sale10b5-149,956$16.32170,981
2025-11-18Sale10b5-175,633$16.07220,937
2025-11-17Sale10b5-118,572$16.11298,070

The 8 most recent of 12 lines, each as reported on the Form 4. "10b5-1" marks a trade the filing reports under a pre-arranged trading plan. View every Form 4 filing on EDGAR →

Tyra Biosciences’s named executive officers, FY2024

as the company reported each
Named executive officerRoleFY2024 total
Todd HarrisChief Executive Officer$7,570,066
Douglas WarnerChief Medical Officer$4,725,517
Daniel Bensen · this pageChief Operating Officer$2,655,199

The full Tyra Biosciences compensation record

free company brief

This page is one person within Tyra Biosciences's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Tyra Biosciences's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Daniel Bensen's compensation dossier · One-time report. No refunds.